You’ll see who these companies are, where they are located, and how they fit into the global ibuprofen supply chain.Read More
Analyze FDA FDF NDC submissions between June and August 2025 to uncover trends, regulatory insights, and what the data reveals about pharma pipelines.Read More
Market intelligence compresses due diligence timelines by bringing supplier data, regulatory signals, and market context together—without cutting corners or increasing risk.Read More
Prices were tracked manually. Decisions were often made based on past relationships, not real-time data. It worked, until it didn’t.Read More
Semaglutide is everywhere right now. If you work in pharma, you’ve probably heard about it in meetings, emails, or sourcing calls more times than you can count.Read More
Understand how API consumption data improves smart sourcing strategy, reduces risks, optimizes suppliers, and boosts decision-making for pharma companies.Read More
Bringing a new drug to the market is not a straight road. It is long, expensive, highly regulated, and full of checkpoints.Read More
A Drug Master File (DMF) in the US (as defined by the U.S. Food and Drug Administration) that provide the confidential technical details about an API’s quality, impurity profile, manufacturing process, and controls.Read More
If you work in pharma and you’re not reading audit reports properly, you’re basically asking for trouble.Read More
When a drug’s patent expires, it’s like a door swinging open for generic players, API makers, and formulation experts to rush in. That’s where the real action (and profit) starts.Read More